[Treatment of PPHN with iNO in an Infant with Trombophilia and Thrombus in PDA. Clinical Case.]

PPHN is common in 1-2/1000 newborn infants. The morbidity and mortality accompanying the disease are extremely high. The treatment is frequently ineffective. The therapy with iNO is the fir l strategy based therapy of PPHN. We present the clinical case of an infant with congenital pneumonia and secondary PPHN treated with iNO. During the clinical observation of the infant congenital trombophilia was diagnosed, due to the presence of a thrombus in PDA. The outcome was favorable.